Novel indole and triazole based hybrid molecules exhibit potent anti-adipogenic and antidyslipidemic activity by activating Wnt3a/β-catenin pathway

Ginsberg, 2009, The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus, J. Cardiometab. Syndr., 4, 113, 10.1111/j.1559-4572.2008.00044.x

Njeru, 2016, High rates of diabetes mellitus, pre-diabetes and obesity among somali immigrants and refugees in Minnesota: a retrospective chart review, J. Immigr. Minor. Health, 18, 1343, 10.1007/s10903-015-0280-3

Ofei, 2005, Obesity - a preventable disease, Ghana Med. J., 39, 98

Zammit, 2016, Abdominal obesity is a risk factor for dysexecutive function in chronic kidney disease, Prev. Med. Rep., 4, 128, 10.1016/j.pmedr.2016.06.007

Pan, 2016, Molecular mechanisms of the anti-obesity effect of bioactive compounds in tea and coffee, Food Funct., 7, 4481, 10.1039/C6FO01168C

Beg, 2015, A clerodane diterpene inhibit adipogenesis by cell cycle arrest and ameliorate obesity in C57BL/6 mice, Mol. Cell. Endocrinol., 399, 373, 10.1016/j.mce.2014.09.024

Wang, 2013, Tracking adipogenesis during white adipose tissue development, expansion and regeneration, Nat. Med., 19, 1338, 10.1038/nm.3324

Soriano-Maldonado, 2016, Severity of obesity and cardiometabolic risk factors in adults: sex differences and role of physical activity. The HERMEX study, Int. J. Cardiol., 223, 352, 10.1016/j.ijcard.2016.07.253

Han, 2016, Anti-adipogenic effect of glycoside St-E2 and glycoside St-C1 isolated from the leaves of Acanthopanax henryi (Oliv.) harms in 3T3-L1 cells, Biosci. Biotechnol. Biochem., 80, 2391, 10.1080/09168451.2016.1217150

Rabiee, 2016, Nuclear phosphoproteome analysis of 3T3-L1 preadipocyte differentiation reveals system-wide phosphorylation of transcriptional regulators, Proteomics, 17, 10.1002/pmic.201600248

Ruiz-Ojeda, 2016, Cell models and their application for studying adipogenic differentiation in relation to obesity: a review, Int. J. Mol. Sci., 17, 10.3390/ijms17071040

Rajan, 2014, Adipocyte transdifferentiation and its molecular targets, Differ. Res. Biol. Divers., 87, 183, 10.1016/j.diff.2014.07.002

Moseti, 2016, Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules, Int. J. Mol. Sci., 17, 10.3390/ijms17010124

Cereijo, 2015, Thermogenic brown and beige/brite adipogenesis in humans, Ann. Med., 47, 169, 10.3109/07853890.2014.952328

Wang, 2008, Peroxisome proliferator-activated receptor-gamma gene: a key regulator of adipocyte differentiation in chickens, Poult. Sci., 87, 226, 10.3382/ps.2007-00329

Mariman, 2010, Adipocyte extracellular matrix composition, dynamics and role in obesity, Cell. Mol. Life Sci. CMLS, 67, 1277, 10.1007/s00018-010-0263-4

Viegas-Junior, 2007, Molecular hybridization: a useful tool in the design of new drug prototypes, Curr. Med. Chem., 14, 1829, 10.2174/092986707781058805

Velezheva, 2004, Novel pyridazino[4,3-b]indoles with dual inhibitory activity against Mycobacterium tuberculosis and monoamine oxidase, J. Med. Chem., 47, 3455, 10.1021/jm030479g

Andreani, 2008, Antitumor activity of bis-indole derivatives, J. Med. Chem., 51, 4563, 10.1021/jm800194k

Knott, 2009, First total synthesis of the whole series of the antiostatins A and B, Chem. Commun. (Camb.), 1467, 10.1039/b821039j

Regina, 2007, Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity, J. Med. Chem., 50, 5034, 10.1021/jm070488f

Pierson, 2009, 5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity, J. Med. Chem., 52, 3855, 10.1021/jm900409x

Sashidhara, 2010, Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives, Bioorg. Med. Chem. Lett., 20, 6504, 10.1016/j.bmcl.2010.09.055

Lehmann, 2004, Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target, Bioorg. Med. Chem. Lett., 14, 4445, 10.1016/j.bmcl.2004.06.057

Yan, 2010, An efficient one-pot synthesis of heterocycle-fused 1,2,3-triazole derivatives as anti-cancer agents, Bioorg. Med. Chem. Lett., 20, 5225, 10.1016/j.bmcl.2010.06.141

Wang, 2010, Synthesis of novel sulfanilamide-derived 1,2,3-triazoles and their evaluation for antibacterial and antifungal activities, Eur. J. Med. Chem., 45, 4631, 10.1016/j.ejmech.2010.07.031

Shanmugavelan, 2011, Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis, Bioorg. Med. Chem. Lett., 21, 7273, 10.1016/j.bmcl.2011.10.048

Behbehani, 2011, Applications of 2-arylhydrazononitriles in synthesis: preparation of new indole containing 1,2,3-triazole, pyrazole and pyrazolo[1,5-a]pyrimidine derivatives and evaluation of their antimicrobial activities, Eur. J. Med. Chem., 46, 1813, 10.1016/j.ejmech.2011.02.040

Jordao, 2009, Antiviral evaluation of N-amino-1,2,3-triazoles against Cantagalo virus replication in cell culture, Eur. J. Med. Chem., 44, 3777, 10.1016/j.ejmech.2009.04.046

da Silva Fde, 2009, Synthesis, HIV-RT inhibitory activity and SAR of 1-benzyl-1H-1,2,3-triazole derivatives of carbohydrates, Eur. J. Med. Chem., 44, 373, 10.1016/j.ejmech.2008.02.047

Shafi, 2012, Synthesis of novel 2-mercapto benzothiazole and 1,2,3-triazole based bis-heterocycles: their anti-inflammatory and anti-nociceptive activities, Eur. J. Med. Chem., 49, 324, 10.1016/j.ejmech.2012.01.032

Jordao, 2011, Synthesis and anti-HSV-1 activity of new 1,2,3-triazole derivatives, Bioorg. Med. Chem., 19, 1860, 10.1016/j.bmc.2011.02.007

Kelley, 1995, 1-(Fluorobenzyl)-4-amino-1H-1,2,3-triazolo[4,5-c]pyridines: synthesis and anticonvulsant activity, J. Med. Chem., 38, 4131, 10.1021/jm00020a030

Kinfe, 2013, Evaluation of the Influence of thiosemicarbazone-triazole hybrids on genes implicated in lipid oxidation and accumulation as potential anti-obesity agents, Bioorg. Med. Chem. Lett., 23, 5275, 10.1016/j.bmcl.2013.08.028

Kothandaraman, 2011, Gold-catalyzed cycloisomerizations of 1-(2-(tosylamino)phenyl)prop-2-yn-1-ols to 1H-indole-2-carbaldehydes and (E)-2-(iodomethylene)indolin-3-ols, J. Org. Chem., 76, 7633, 10.1021/jo201208e

Hochegger, 2008, Cyclin-dependent kinases and cell-cycle transitions: does one fit all?, Nat. Rev. Mol. Cell Biol., 9, 910, 10.1038/nrm2510

Liu, 2006, Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin, Mol. Cell. Biol., 26, 5827, 10.1128/MCB.00441-06

Waki, 2007, The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression, Cell Metab., 5, 357, 10.1016/j.cmet.2007.03.010

Gedaly, 2014, Targeting the Wnt/beta-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535, PLoS One, 9, e99272, 10.1371/journal.pone.0099272

Kong, 2004, Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins, Nat. Med., 10, 1344, 10.1038/nm1135

Kim, 2011, Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion, J. Nutr. Biochem., 22, 910, 10.1016/j.jnutbio.2010.08.003

Varshney, 2014, Rohitukine inhibits in vitro adipogenesis arresting mitotic clonal expansion and improves dyslipidemia in vivo, J. Lipid Res., 55, 1019, 10.1194/jlr.M039925

Shankar, 2015, Cucumis melo ssp. Agrestis var. Agrestis ameliorates high fat diet induced dyslipidemia in Syrian Golden hamsters and inhibits adipogenesis in 3T3-L1 adipocytes, Pharmacogn. Mag., 11, S501, 10.4103/0973-1296.172945

Zhang, 2009, Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods, Mol. Nutr. Food Res., 53, 921, 10.1002/mnfr.200800517

Treguier, 2011, Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters, Eur. J. Clin. Invest., 41, 921, 10.1111/j.1365-2362.2011.02478.x

Nakaya, 2011, Peroxisome proliferator-activated receptor-alpha activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway, Arterioscler. Thromb. Vasc. Biol., 31, 1276, 10.1161/ATVBAHA.111.225383

Frith, 2008, Transcriptional control of mesenchymal stem cell differentiation, Transfus. Med. Hemotherapy Off. Organ Dtsch. Ges. Transfusionsmed. Immunhamatol., 35, 216, 10.1159/000127448

Hu, 2009, Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation, Phytomed. Int. J. phytother. Phytopharm., 16, 864

Horikawa, 2012, Polymethoxyflavonoids from Kaempferia parviflora induce adipogenesis on 3T3-L1 preadipocytes by regulating transcription factors at an early stage of differentiation, Biol. Pharm. Bull., 35, 686, 10.1248/bpb.35.686

Choi, 2012, Sulforaphane inhibits mitotic clonal expansion during adipogenesis through cell cycle arrest, Obes. (Silver Spring), 20, 1365, 10.1038/oby.2011.388

Kim, 2012, (-)-Epigallocatechin gallate suppresses adipocyte differentiation through the MEK/ERK and PI3K/Akt pathways, Cell Biol. Int., 36, 147, 10.1042/CBI20110047

Mitterberger, 2013, Mechanisms of resveratrol-induced inhibition of clonal expansion and terminal adipogenic differentiation in 3T3-L1 preadipocytes, J. Gerontol. Ser. A Biol. Sci. Med. Sci., 68, 1356, 10.1093/gerona/glt019

Kwon, 2012, An inhibitory effect of resveratrol in the mitotic clonal expansion and insulin signaling pathway in the early phase of adipogenesis, Nutr. Res., 32, 607, 10.1016/j.nutres.2012.06.014

Chen, 2012, The beta-catenin/TCF complex as a novel target of resveratrol in the Wnt/beta-catenin signaling pathway, Biochem. Pharmacol., 84, 1143, 10.1016/j.bcp.2012.08.011

Bennett, 2002, Regulation of Wnt signaling during adipogenesis, J. Biol. Chem., 277, 30998, 10.1074/jbc.M204527200

Yun, 2012, Widdrol blocks 3T3-L1 preadipocytes growth and differentiation due to inhibition of mitotic clonal expansion, J. Microbiol. Biotechnol., 22, 806, 10.4014/jmb.1110.10039

Laudes, 2011, Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes, J. Mol. Endocrinol., 46, R65

Bowen, 2016, Wnt4 antagonises Wnt3a mediated increases in growth and glucose stimulated insulin secretion in the pancreatic beta-cell line, INS-1, Biochem. Biophys. Res. Commun., 479, 793, 10.1016/j.bbrc.2016.09.130

Kim, 2016, Merlin inhibits Wnt/beta-catenin signaling by blocking LRP6 phosphorylation, Cell Death Differ., 23, 1638, 10.1038/cdd.2016.54

Ouyang, 2016, MiR-181a-5p regulates 3T3-L1 cell adipogenesis by targeting Smad7 and Tcf7l2, Acta Biochim. Biophys. Sin., 48, 1034, 10.1093/abbs/gmw100

Lecarpentier, 2016, Opposite interplay between PPAR gamma and canonical Wnt/beta-catenin pathway in amyotrophic lateral sclerosis, Front. Neurol., 7, 100, 10.3389/fneur.2016.00100

Chen, 2016, Inhibiting DNA methylation switches adipogenesis to osteoblastogenesis by activating Wnt10a, Sci. Rep., 6, 25283, 10.1038/srep25283

Garnick, 1998, Insurance agents: ignored players in health insurance reform, Health Aff. (Millwood), 17, 137, 10.1377/hlthaff.17.2.137

Staels, 1998, Mechanism of action of fibrates on lipid and lipoprotein metabolism, Circulation, 98, 2088, 10.1161/01.CIR.98.19.2088

Pawlak, 2015, Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease, J. Hepatol., 62, 720, 10.1016/j.jhep.2014.10.039

Staels, 2008, Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease, Nat. Clin. Pract. Cardiovasc. Med., 5, 542, 10.1038/ncpcardio1278